Front Row Advisors LLC Johnson & Johnson Transaction History

Front Row Advisors LLC

$271 Million
Q3 2024

A detailed history of Front Row Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Front Row Advisors LLC holds 6,896 shares of JNJ stock, worth $1.07 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

6,896

Previous 9,543 27.74%

Holding current value

$1.07 Million

Previous $1.39 Million 19.87%

% of portfolio

0.41%

Previous 0.49%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $385,085 - $443,054	-2,647 Reduced 27.74%	6,896 $1.12 Million
Q2 2024 Aug 15, 2024	BUY	$144.38 - $157.78 $123,589 - $135,059	856 Added 9.85%	9,543 $1.39 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $340,242 - $356,726	2,192 Added 33.75%	8,687 $1.37 Million
Q4 2023 Feb 15, 2024	SELL	$145.6 - $158.88 $373,172 - $407,209	-2,563 Reduced 28.3%	6,495 $1.02 Million
Q3 2023 Nov 15, 2023	SELL	$155.75 - $174.48 $105,131 - $117,774	-675 Reduced 6.94%	9,058 $1.41 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $4,630 - $4,983	-30 Reduced 0.31%	9,733 $1.61 Million
Q1 2023 May 22, 2023	BUY	$151.05 - $180.26 $1.25 Million - $1.49 Million	8,250 Added 545.27%	9,763 $1.51 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $1.29 Million - $1.54 Million	-8,546 Reduced 84.96%	1,513 $976,000
Q4 2022 Feb 15, 2023	BUY	$160.2 - $179.79 $961 - $1,078	6 Added 0.06%	10,059 $1.78 Million
Q3 2022 Nov 15, 2022	SELL	$161.33 - $179.52 $10,809 - $12,027	-67 Reduced 0.66%	10,053 $1.64 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $2,186 - $2,418	-13 Reduced 0.13%	10,120 $1.8 Million
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $1,265 - $1,436	-8 Reduced 0.08%	10,133 $1.8 Million
Q4 2021 Mar 09, 2022	SELL	$155.93 - $173.01 $3,118 - $3,460	-20 Reduced 0.2%	10,141 $1.74 Million
Q2 2021 Aug 23, 2021	SELL	$159.48 - $171.07 $198,712 - $213,153	-1,246 Reduced 10.92%	10,161 $1.81 Million
Q1 2021 Apr 28, 2021	SELL	$153.07 - $170.48 $2,296 - $2,557	-15 Reduced 0.13%	11,407 $1.88 Million
Q3 2020 Nov 30, 2020	SELL	$140.38 - $153.83 $11,932 - $13,075	-85 Reduced 0.74%	11,422 $1.65 Million
Q2 2020 Aug 17, 2020	SELL	$128.81 - $155.51 $41,090 - $49,607	-319 Reduced 2.7%	11,507 $1.62 Million
Q1 2020 May 08, 2020	BUY	$111.14 - $153.99 $63,349 - $87,774	570 Added 5.06%	11,826 $1.77 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $26,775 - $30,752	-210 Reduced 1.83%	11,256 $1.64 Million
Q3 2019 Nov 08, 2019	SELL	$126.95 - $142.14 $43,416 - $48,611	-342 Reduced 2.9%	11,466 $1.48 Million
Q2 2019 Aug 27, 2019	SELL	$131.15 - $144.24 $46,427 - $51,060	-354 Reduced 2.91%	11,808 $1.65 Million
Q1 2019 May 17, 2019	SELL	$125.72 - $139.79 $257,097 - $285,870	-2,045 Reduced 14.39%	12,162 $1.7 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $255,752 - $307,802	-2,082 Reduced 12.78%	14,207 $1.83 Million
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $2,431 - $2,857	20 Added 0.12%	16,289 $2.24 Million
Q2 2018 Jul 31, 2018	SELL	$119.4 - $131.76 $56,476 - $62,322	-473 Reduced 2.83%	16,269 $2.1 Million
Q1 2018 May 21, 2018	BUY	$125.1 - $148.14 $10,883 - $12,888	87 Added 0.52%	16,742 $2.15 Million
Q4 2017 Feb 01, 2018	BUY	$131.22 - $143.62 $2.19 Million - $2.39 Million	16,655	16,655 $2.33 Million

Others Institutions Holding JNJ

# of Institutions

4,269

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account

Front Row Advisors LLC Johnson & Johnson Transaction History